How TriCore Benefits TRI Sponsors

Tricore Reference Laboratory
January 14, 2025

Elizabeth Donovan, PhD, NRCC-CC

TriCore Research Institute (TRI) is owned by TriCore, an independent, not-for-profit clinical laboratory based in Albuquerque, New Mexico. Since joining TRI in June 2024, I’ve had the opportunity to explore how our connection to TriCore enhances TRI’s capabilities and brings unique advantages to our sponsors.


Platform Accessibility

TRI has access to TriCore’s array of instrumentation that can be used to support studies for benchmarking, proof-of-concept, pre-market approval (PMA) and 510K FDA submissions. In addition, TRI has space to install a sponsor’s investigational device to conduct research.

 

Collaboration

TRI’s dedicated staff – which includes medical directors, lab scientists, principal investigators, research coordinators clinical lab assistants, and phlebotomists – have the ability to work closely with TriCore’s clinical reference lab when needed. This collaboration fosters a seamless exchange of expertise and sharing the same workspace helps us build strong relationships with the clinical reference lab team.

 

TRI began with infectious disease nearly 15 years ago, but since that time, TRI has expanded and conducts different types of research studies across many disciplines of laboratory medicine. TRI collaborates with TriCore’s medical directors who have additional expertise in microbiology, chemistry, oncology, sequencing, allergy, autoimmune, gammopathies, cytology, urinalysis, and hematology.

 

How TRI Can Benefit Laboratory Medicine

In addition to supporting advancements for analytical and clinical specificity, and sensitivity of clinical assays, TRI helps sponsors support:

  • Automation: Automated testing leads to greater efficiency and reduced hands-on work. Artificial intelligence might play an increasingly critical role, too.
  • Optimizing Laboratory Space: Space limitations are a common challenge for laboratories. Developing smaller instrumentation could help address these constraints.
  • Expanding Point-of-Care Testing: Advancements in point-of-care testing could lead to faster diagnosis and treatment.

Learn more about TriCore Research
Institute's Biorepository

Comprehensive specimen procurement services to point you down the right path.

Insights

January 14, 2025

How TriCore Benefits TRI Sponsors

TriCore Research Institute (TRI) is owned by TriCore, an independent, not-for-profit clinical laboratory based in Albuquerque, New Mexico. Since joining TRI in June 2024, I’ve had the opportunity to explore how our connection to TriCore enhances TRI’s capabilities and brings unique advantages to our sponsors. Platform Accessibility TRI has access to TriCore’s array of instrumentation…

Read More
December 17, 2024

TriCore Research Institute (TRI) Attends the Confederation Latin American Biochemistry Clinical (COLABIOCLI) Conference

  This past October, attendees from Latin America and around the world gathered in Cartagena, Colombia to attend the Confederacion Latinoamericana de Bioquimica Clinica Conferencia (COLABIOCLI). Closely aligned with the Association for Diagnostics & Laboratory Medicine (ADLM), the COLABIOCLI’s main focuses are on sharing lab expertise and educating laboratorians in Latin America  This year’s conference…

Read More
May 14, 2024

Point of Care Testing: A Blessing or a Burden?

Point-of-care testing (POCT) refers to medical diagnostic testing that is performed near the patient, often at the bedside, rather than in a centralized laboratory. This type of testing provides rapid results, allowing healthcare providers to make immediate treatment decisions. POCT devices are typically portable, easy to use, and require minimal training. They are suitable for…

Read More